Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-04 4:10 pm |
Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer |
10,086 | $3.43 | $34,595 | 157,914 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-04 4:08 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
10,885 | $3.43 | $37,336 | 430,931 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:21 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
3,305 | $4.26 | $14,079 | 215,718 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:20 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
11,702 | $4.24 | $49,616 | 731,816 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:19 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
3,894 | $4.25 | $16,550 | 312,147 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:22 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,413 | $4.45 | $24,088 | 81,023 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:21 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
6,950 | $4.45 | $30,928 | 102,291 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:20 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President & CEO |
16,644 | $4.45 | $74,066 | 308,518 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:19 pm |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
4,358 | $4.45 | $19,393 | 81,643 (Direct) |
View |
| 2025-01-14 Sale |
2025-01-15 4:18 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
3,087 | $5.09 | $15,713 | 109,241 (Direct) |
View |
| 2025-01-14 Sale |
2025-01-15 4:17 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,191 | $5.13 | $6,110 | 86,436 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-26 4:29 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO&CBO |
6,500 | $5.65 | $36,725 | 112,328 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-03 4:43 pm |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
5,999 | $5.82 | $34,914 | 86,001 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 4:13 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,357 | $9.88 | $13,407 | 117,004 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 4:10 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
12,115 | $9.86 | $119,454 | 322,839 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:36 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
3,966 | $7.45 | $29,547 | 118,361 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
13,033 | $7.46 | $97,226 | 334,954 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:32 pm |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
3,764 | $7.46 | $28,079 | 175,669 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 4:30 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
3,967 | $7.5019 | $29,760 | 87,627 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-24 4:21 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
138,000 | $0 | 215,718 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-24 4:20 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
435,000 | $0 | 731,816 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-24 4:19 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
213,750 | $0 | 312,147 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-24 4:18 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
124,500 | $0 | 206,143 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-24 4:16 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer |
189,000 | $0 | 294,000 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-24 4:15 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
154,500 | $0 | 234,500 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:09 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2024-07-08 Option Award |
2024-07-09 4:11 pm |
N/A 2034-07-08 |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:22 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:21 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:20 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:20 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:19 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:17 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Hyman Steven Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:16 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:15 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:15 pm |
N/A 2034-06-05 |
Voyager Therapeutics Inc. | VYGR | Colon Grace Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 4:17 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-26 5:27 pm |
N/A 2034-03-25 |
Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:06 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
93,000 | $0 | 154,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:04 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
115,500 | $0 | 168,594 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:03 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
150,000 | $0 | 222,327 (Direct) |
View |